Attend visiongain's b2b conference, WIRELESS SPORT: EXPLORING FUTURE BRANDING AND REVENUE-GENERATING OPPORTUNITIES WITH SPORT IN WIRELESS, a unique conference where the mobile industry and the sports world meet to discuss content and branding partnerships. Key representatives from the sports world and mobile industry will gather at this unique venue at Chelsea Village, home ground of the Chelsea Football team. - December 03, 2004

According to the latest visiongain report "SMS in the U.S. - The Right Technology for Cellular Messaging Success?" text Messaging, or SMS, has been hugely successful in many parts of the world, but not so in the United States. The report question why this is and debates whether SMS ever be as popular in the U.S. market compared with the rest of the world. - December 03, 2004

According to the latest visiongain report "SavaJe - Challenging the Mobile Operating Market", the mobile handset market operating system market has evolved rapidly in the last 3 years as handsets become increasingly sophisticated. SavaJe (pronounced savage - the name is an comes from of Java SE) is one of a handful of companies hoping to compete in the market which is currently dominated by Symbian, with Microsoft also vying for control. - December 03, 2004

A new report published by visiongain entitled " Sea Strike Weapon" forecasts the future of modern warfare as light mobile troops operating independently in littoral areas. The US military is spiraling its capabilities towards sea based warfare during the first quarter of the 21st century and other western forces are readying themselves for littoral warfare. Therefore an increasing need for a suite of defensive weapons systems that can simultaneously defend both sea based assets and amphibious forces. - December 03, 2004

Attend the visiongain's b2b conference, ANTI-MIGRAINE THERAPIES 2005: IMPROVING DISEASE UNDERSTANDING, DRUG DELIVERY AND FUTURE TARGETS. This conference's objective is to provide a unique forum to discuss the new developments in significant areas of the anti-migraine therapies market. This includes new research data to innovations in drug delivery to future targets for drugs. - December 03, 2004